Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Tracking error measures how closely an index fund follows its benchmark. Grasp its implications to evaluate fund tracking accuracy.
14,431 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A sharp pullback in the IGV ETF puts a spotlight on Oracle’s ability to generate free cash flow amid AI investments. ...
Goldman Sachs warns that leveraged stock bets are extremely focused on AI stocks, creating risk if AI sentiment shift...
Home listings are cooling fast as sellers reset prices. The latest data show a record decline in home asking prices, ...
MicroStrategy announces a sweeping Digital Credit Capital Framework that reshapes how it funds Bitcoin purchases and ...
A leading economist contends the FED will keep rates steady through year-end, challenging current market bets and sha...
A shopper thought she bought a patriotic made in USA shirt, but the return address told a different story. This guide...
Palantir Technologies and NVIDIA expanded their collaboration to accelerate government-grade AI models, sending Palan...
Trump granted clemency to 11 people on a Friday ahead of July 4, spotlighting emissions-related cases and a partner o...
As Solana enters a two-decade horizon, this article examines how AI-driven finance and real-world asset tokenization ...
A $29 billion AI-linked stock offering goes live this week, setting up a crucial test of investor appetite for AI pla...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...